Nekton Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-152,632
Closed -$15.8M 17
2022
Q4
$15.8M Hold
152,632
3.56% 14
2022
Q3
$12.9M Buy
+152,632
New +$12.9M 3.52% 10